Edges in Network
| Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
| Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
| Node | RAC2 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → RAC2 |
| (<<) FNBP1 → RAC2 |
| (<<) HLA-DOA → RAC2 |
| (<<) HLA-G → RAC2 |
| (<<) INPP5D → RAC2 |
| (<<) LPXN → RAC2 |
| (<<) LRCH4 → RAC2 |
| (<<) RHOG → RAC2 |
| (<<) STAT4 → RAC2 |
| Downstream (Children) |
|---|
| RAC2 → CACNA1E (>>) |
| RAC2 → CBFA2T3 (>>) |
| RAC2 → CD274 (>>) |
| RAC2 → CHI3L1 (>>) |
| RAC2 → CHST12 (>>) |
| RAC2 → CORO1A (>>) |
| RAC2 → CSTA (>>) |
| RAC2 → EFHD2 (>>) |
| RAC2 → ELF3 (>>) |
| RAC2 → GBP2 (>>) |
| RAC2 → HLA-A (>>) |
| RAC2 → HLA-F (>>) |
| RAC2 → HS2ST1 (>>) |
| RAC2 → ICAM2 (>>) |
| RAC2 → IRF1 (>>) |
| RAC2 → ISG20 (>>) |
| RAC2 → ITGB7 (>>) |
| RAC2 → KRTAP4-1 (>>) |
| RAC2 → LCP1 (>>) |
| RAC2 → LTB (>>) |
| RAC2 → MAL (>>) |
| RAC2 → MAPK9 (>>) |
| RAC2 → PIK3CD (>>) |
| RAC2 → PIK3R5 (>>) |
| RAC2 → PIP4K2A (>>) |
| RAC2 → PLCD4 (>>) |
| RAC2 → PLCG2 (>>) |
| RAC2 → PRKCB (>>) |
| RAC2 → PRKCQ (>>) |
| RAC2 → RASSF5 (>>) |
| RAC2 → RHOF (>>) |
| RAC2 → STAT1 (>>) |
| RAC2 → STK17B (>>) |
| RAC2 → SYK (>>) |
| RAC2 → TNFAIP3 (>>) |
| RAC2 → TRAF1 (>>) |
| RAC2 → TRAF6 (>>) |
| RAC2 → TSC22D1 (>>) |
| RAC2 → UBE2L6 (>>) |
| RAC2 → VAV1 (>>) |
| RAC2 → VEGFA (>>) |
